Drawing for B BIONICS INSTITUTE

USPTO serial 79342541

B BIONICS INSTITUTE

Reviewed by CopyMark Law Group

Reg. 7435181Status 700Registered
Filing date
Status date
Registration date
Jul 9, 2024
Examiner
GAGLIARDI, JEANINE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with B BIONICS INSTITUTE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Anne Wang

Anne Wang FROST BROWN TODD LLP301 East Fourth Street3300 Great American TowerCincinnati, OH 45202

Goods and services

ClassDescriptionStatusFirst use
010Medical apparatus and instruments, namely, medical apparatus and instruments for use in neuromodulation and medical apparatus and instruments for the diagnosis, monitoring, management and treatment of hearing disorders; electronic medical apparatus, namely, electronic medical apparatus for use in neuromodulation and the electronic medical apparatus for the diagnosis, monitoring, management and treatment of hearing disorders; medical diagnostic devices and instruments, namely, medical diagnostic devices and instruments for use in neuromodulation and medical diagnostic devices and instruments for the diagnosis, monitoring, management and treatment of hearing disorders; medical devices and instruments for monitoring and treating health and medical conditions, namely, medical devices and instruments for monitoring and treating health and medical conditions by way of neuromodulation and medical devices and instruments for monitoring and treating health and medical conditions, namely, hearing disorders, epilepsy and parkinson's disease; medical implants, namely, medical implants for use in neuromodulation and medical implants for the diagnosis, monitoring, management and treatment of hearing disorders, epilepsy and parkinson's disease, all being made from artificial materials; wearable medical devices, namely, wearable medical devices for use in neuromodulation and wearable medical devices for the diagnosis, monitoring, management and treatment of hearing disorders, epilepsy and parkinson's disease; hearing aids; apparatus for use in alleviating hearing disorders, namely, hearing aids and cochlea implants made of artificial materials; apparatus for use in treating hearing disorders, namely, hearing aids and cochlea implants made of artificial materials; apparatus for use in the diagnosis, monitoring and treatment of neurological conditions and central nervous system disorders, including parkinson's disease and epilepsy; sensors being measurement apparatus for medical use, namely, biofeedback sensorsACTIVE—
016Printed matter, namely, books, journals, magazines and brochures in the field of medical research and medical practice; printed publications, namely, books, journals, magazines and brochures in the field of medical research and medical practice; printed journals in the field of medical research and medical practice; printed newsletters and printed magazines in the field of medical research and medical practice; all the aforementioned being in relation to medical research and medical mattersACTIVE—
042Medical research; medical research in the field of neurological conditions and central nervous system disorders; medical research in the field of parkinson's disease; medical research in the field of epilepsy; medical research in the field of hearing disorders; technological research and design in the field of medical devices, apparatus and instruments; technological research and design of computer hardware, firmware and software for use in the medical field; software as a service (saas) for use in the medical field featuring software for diagnosing, monitoring, managing, and treating health and medical conditions; platforms as a service (paas) for use in the medical field featuring software platforms for diagnosing, monitoring, managing, and treating health and medical conditions; installation, maintenance and repair of computer firmware and computer software for use in the medical field, namely, for use with medical devices for the diagnosis, monitoring, management and treatment of health and medical conditionsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 4, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 13, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 13, 2024FIMPFINAL DISPOSITION PROCESSED—
Oct 9, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 12, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 12, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Sep 12, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 12, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 12, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 12, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 9, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 9, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 25, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 23, 2024GPNXNOTIFICATION PROCESSED BY IB—
Apr 23, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 3, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 3, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 3, 2024OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 19, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 27, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 27, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 27, 2024ALIEASSIGNED TO LIE—
Dec 11, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Nov 22, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 22, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Oct 5, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 5, 2023NREVNOTICE OF REVIVAL - E-MAILED—
Oct 5, 2023PETGPETITION TO REVIVE-GRANTED—
Oct 5, 2023PROATEAS PETITION TO REVIVE RECEIVED—
Oct 3, 2023MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 3, 2023MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 3, 2023ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 13, 2023RFNTREFUSAL PROCESSED BY IB—
Mar 17, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 17, 2023RFRRREFUSAL PROCESSED BY MPU—
Jan 25, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 24, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 19, 2023DOCKASSIGNED TO EXAMINER—
Jun 28, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 22, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 21, 2022LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jun 16, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance